O'Dell Group’s Cardinal Health CAH Stock Holding History

O'Dell Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-191	Closed	-$10K	–	421
2022 Q2	$10K	Hold	191	–	–	﹤0.01%	277
2022 Q1	$11K	Hold	191	–	–	﹤0.01%	306
2021 Q4	$10K	Hold	191	–	–	﹤0.01%	301
2021 Q3	$9K	Buy	+191	New	+$10.4K	﹤0.01%	300

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

O'Dell Group's CAH Position: Q3 2022 in Review

O'Dell Group sold out of Cardinal Health (CAH) in Q3 2022, closing a stake of 191 shares — an estimated $10K sold.

O'Dell Group first reported a position in CAH in Q3 2021 and held it in 4 quarters. The position peaked at $11K in Q1 2022. 849 funds tracked by Wall St. Rank hold CAH as of Q3 2022.

O'Dell Group reported no remaining Cardinal Health position as of Q3 2022 after selling out during the quarter.
O'Dell Group sold 191 Cardinal Health shares in Q3 2022, an estimated $10K.
O'Dell Group first reported a position in Cardinal Health in Q3 2021 and held it in 4 quarters.
O'Dell Group's Cardinal Health position peaked at $11K in Q1 2022.
849 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2022.

Based on O'Dell Group's 13F filing for Q3 2022, filed 8 Nov 2022.